Objectives The prevalence of HTLV infection in Sweden is presumed to be low. In our study
we described clinical and laboratory characteristics of patients with HTLV-infection followed …

Sweden is a country with a low prevalence of human lymphotropic T-cell virus (HTLV)
infection, estimated at < 0.005%, but the infection rate is notably higher in specific risk …

Objective: To examine the clinical burden and disease spectrum, as well as time trends for
human T-cell leukemia virus type 1 (HTLV-1) and HTLV type 2 (HTLV-2) hospital …

Acquired immune deficiency syndrome (AIDS) has been etiologically linked with the human
T-cell lymphotropic virus HTLV-III. In a study on the prevalence of antibodies to this virus in …

Published and unpublished data on the HTLV-I seroprevalence in 13 European countries
(sample a total of 79.549 persons) was subject to meta-analysis. HTLV-I infection was …

Background HTLV-1 infection is a neglected disease that affects over 10 million people
worldwide. Roughly 5% of HTLV-1 carriers develop HTLV-1-associated myelopathy (HAM) …

Abstract Objectives Human T Cell Leukaemia Virus Type 1 (HTLV-1) causes overt disease
in around 10% of cases, including HTLV-1-associated myelopathy (HAM). HTLV-1 infection …

An epidemiological survey on the presence of serum antibodies to human T lymphotropic
retrovirus III (HTLV-III) is reported. The study was carried out on people living in large as well …

Abstract Objectives In Europe, the vast majority of HTLV-1-infected individuals originate from
highly endemic regions (eg, West Indies, sub-Saharan Africa, South America). The only …

Human T lymphotropic viruses (HTLVs) have a limited spread in the general populations of
Western countries. Consequently, the transfusional risk for HTLV is considered to be low in …